Navigation Links
Tastier tomatoes in the future?

Tomatoes are good for you. They strengthen the immune system and can prevent heart and circulatory disease. Now, researchers from the Max Planck Institute of Molecular Plant Physiology, in co-operation with Israeli scientists, have identified DNA fragments in tomatoes that make their contents both healthy and tasty. The researchers crossed wild tomatoes with cultured ones, then investigated the contents and genetic make-up of the hybrid. The results could allow tomato growers to use wild tomatoes to produce cultured tomatoes with the characteristics they desire (Nature Biotechnology, March 12, 2006).

Tomatoes are a major nutrient for humans. In 2004, 120,000 tonnes of tomatoes were harvested worldwide - and every year this number increases. Numerous medical studies have shown the health value of tomatoes. Lycopen, the pigment that makes tomatoes red, can for example prevent heart disease. Tomatoes furthermore contain a lot of vitamins C and E, indispensable for human nourishment. But after centuries of cultivation for shape, colour, and other useful qualities, our cultured tomatoes today are of small genetic diversity, in comparison with wild types. This has affected the taste and health value of the fruits.

To cultivate tomato strains with particular characteristics, researchers have to increase the genetic diversity of cultured tomatoes. This can be done either by cross-breeding them with wild tomatoes, or changing their genetic make-up technologically. Scientists from the Max Planck Institute for Molecular Plant Physiology in Golm, and their Israeli colleagues at Hebrew University in Jerusalem, chose the second option. They investigated strains of tomatoes created from the crossing of cultured and wild types. Their goal was to identify the biochemical composition of fruits and determine which factors control their development. The German-Israeli research team used a method of analysis developed at the Max Planck Institute for Molecular Plant Physio
'"/>

Source:Max-Planck-Gesellschaft


Page: 1 2

Related biology news :

1. Anyway you slice it, tomatoes cut through drought with new gene
2. Unique tomatoes tops in disease-fighting antioxidants
3. Scientists genetically engineer tomatoes with enhanced folate content
4. Cellulosic ethanol: Fuel of the future?

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Tastier tomatoes the future

(Date:11/25/2009)...ate University assistant professors recently recei...NSF) to continue research beneficial to understand...00. , Christopher Blackwood, assistant professor...rded grants to support two separate research proje...ter Decomposer Communities and Functions from the ...
(Date:11/24/2009)...have crystallised a protein that may help gut bact...in could be used by probiotic producers to identif... people. , "Probiotics need to interact with cell...if they attach to surfaces in the gut they are mor...r activity," says Dr Nathalie Juge from the Instit...
(Date:11/24/2009)...GE Antarctica has long held secrets of the earth,...ntly, there has been very little information on th... of ice for millions of years. Now, a team of rese...e been funded to the tune of $10 million dollars b...to the bottom of things literally. These scientis...
Breaking Biology News(10 mins):Kent State University professors focus research on the environment with grants totaling $890,000 2A sticky solution for identifying effective probiotics 2LSU gets to the bottom of things -- in Antarctica 2Food Addicts Convention Draws 800 Members from 31 States 5 Nations Around the World 58152 1Food Addicts Convention Draws 800 Members from 31 States 5 Nations Around the World 58152 2Food Addicts Convention Draws 800 Members from 31 States 5 Nations Around the World 58152 3InspireMD Announces the Enrollment of the 1st Patient in the MGuard 28TM 29 Israeli Registry InspireMD Will Also Sponsor a Satellite Program Breakfas 14237 1InspireMD Announces the Enrollment of the 1st Patient in the MGuard 28TM 29 Israeli Registry InspireMD Will Also Sponsor a Satellite Program Breakfas 14237 2InspireMD Announces the Enrollment of the 1st Patient in the MGuard 28TM 29 Israeli Registry InspireMD Will Also Sponsor a Satellite Program Breakfas 14237 3Max Neeman International to Open Phase I IIa Unit 14233 1Max Neeman International to Open Phase I IIa Unit 14233 2
...des an effective way to screen drugs against Hunti...ntine and riluzole ?are most effective at keeping ...er, UT Southwestern Medical Center researchers rep...y of Huntington,s disease models and some HD human...t," said Dr. Ilya Bezprozvanny, associate professo...
...ucted the DNA sequence of a 5-million-year-old ret...tious particles. The retrovirus--named Phoenix--i...ments, some of which may play a role in cancer. T...ious retrovirus from a mobile element in the human...d of retrovirus research. The findings are report...
...own that a three-dimensional ultrasound scanner th...ot. , The scanner could find application in variou...They said the scanner ultimately might enable surg...ty that could prove valuable in space stations or ...to our knowledge, that anyone has used the informa...
Other Biology News:Test reveals effectiveness of potential Huntington's disease drugs 2Scientists resuscitate a 5 million-year-old retrovirus 23-D ultrasound scanner could guide robotic surgeries 23-D ultrasound scanner could guide robotic surgeries 3
(Date:11/24/2009)... REYKJAVIK, Iceland, November 24 /PRNewswire-Fi...today announced the approval of all of its,"first ...District of Delaware,(the "Bankruptcy Court"). deC...f under Chapter 11 of the United States Bankruptcy...ders issued by the Bankruptcy Court allow the comp...
(Date:11/24/2009)...GHAI, Nov. 24 /PRNewswire-Asia/ -- Shanghai Biolax...nistration (SFDA) has approved the,investigational...roject,(Nodlin), an innovative insulin formulation...xy to initiate its first phase I clinical study. ,... high blood glucose and poor,metabolism. The compl...
(Date:11/24/2009)... efficacy endpoint has been met for patients with ..., , QUEBEC CITY, Nov. 24 /PRNewswire-FirstCal...EZ) (the "Company"), a global biopharmaceutical co...oday announced positive efficacy data from a Phase...gate, AEZS-108 (formerly AN-152), in patients with...
(Date:11/24/2009)..., Nov. 24, 2009 Arena Ph...oday that the company is scheduled to present at t...e on December 1, 2009 at 11:30 a.m. Eastern Time (...el in New York City. Jack Lief, Arena,s President ...de an overview of the company, including its clini...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Biolaxy Secures IND Approval for Oral Insulin 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 3
...enta,Incorporated (OTC Bulletin Board: GNTA) today... June 30, 2008. The Company recorded significant,m...lowing:, -- NDA amendment for Genasense(R) in CLL...asense in melanoma updated at EADO, -- Clinical h...axane,lifted by FDA, -- Pharmacokinetics of or...
...stretchable optoelectronics and biologically inspi...maging device, with a layout based on the human ey... Nature, researchers at the University of Illino...gh-performance, hemispherical "eye" camera using a...d electronics, configured in a stretchable, interc...
...r service revenue grows approximately 33% ... - Operating margin of 9.9% for the quarter,- Rec...atio of 1.56 for the ...Corporation (Nasdaq: PRXL ) today announced its f... Year ended June 30, 2008., For the three months ...
Other Biology Technology:Genta Incorporated Announces Second Quarter 2008 Financial Results and Corporate Highlights 2Genta Incorporated Announces Second Quarter 2008 Financial Results and Corporate Highlights 3Genta Incorporated Announces Second Quarter 2008 Financial Results and Corporate Highlights 4Genta Incorporated Announces Second Quarter 2008 Financial Results and Corporate Highlights 5Genta Incorporated Announces Second Quarter 2008 Financial Results and Corporate Highlights 6Genta Incorporated Announces Second Quarter 2008 Financial Results and Corporate Highlights 7Genta Incorporated Announces Second Quarter 2008 Financial Results and Corporate Highlights 8Genta Incorporated Announces Second Quarter 2008 Financial Results and Corporate Highlights 9Genta Incorporated Announces Second Quarter 2008 Financial Results and Corporate Highlights 10Stretchable silicon camera next step to artificial retina 2PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results 2PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results 3PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results 4PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results 5PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results 6PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results 7PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results 8PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results 9PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results 10PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results 11PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results 12PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results 13PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results 14
Donor feline Serum - 100mL from Biomeda Corporation
Monocyte Activation Kit from 3H Biomedical AB
Goat Anti-NPT1 (M-19) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Suction Cups and Assemblies from Parker Hannifin Corporation
Biology Products: